Global Ganja Report

US representatives Earl Blumenauer (D-OR) and Dana Rohrabacher (R-CA), along with ten bipartisan co-sponsors introduced, the Veterans Equal Access Act (VEAA) Nov. 20, to allow our country's veterans to become medical marijuana patients in states where it's legal. The VEAA would allow Veterans Affairs (VA) physicians to recommend medical marijuana to their patients, a right enjoyed by physicians outside of the VA system. "Post traumatic stress and traumatic brain injury are just as damaging and harmful as any injuries that are visible from the outside," said Blumenauer, the bill's author. "Sometimes even more so because of the devastating effect they can have on a veteran's family. We should be allowing these wounded warriors access to the medicine that will help them survive and thrive, including medical marijuana, not treating them like criminals and forcing them into the shadows. It's shameful."

Reaction continues to mount to news that Bob Marley's name is to be further immortalized as a cannabis brand—not just a strain, but an actual brand name. Privateer Holdings, a Seattle-based private equity firm that invests in the cannabis industry, has struck a deal with the estate of the late reggae superstar to launch a global marijuana brand, Financial Times reports. The firm's Marley Natural subsidiary will start marketing its line next year, including "heirloom Jamaican cannabis strains," cannabis-infused skin creams and lip balms, and accessories such as vaporizers and pipes "based on those that Bob preferred."

Following the passage of cannabis legalization measures in Oregon, Alaska and the District of Columbia on election day, the chief of the UN Office on Drugs and Crime (UNODC) on Nov. 12 issued his requisite scolding. UNODC executive director Yury Fedotov told reporters, "I don't see how [the new laws] can be compatible with existing conventions." He added that he plans to address the issue with the US State Department and other UN agencies. He admitted that the legalization measures are part of a global trend that the UNODC is monitoring. (Jurist, Reuters, Nov. 12)

The latest government stats for marijuana arrests show a 9% dip from the previous year. There were 693,481 pot arrests in 2013—88% for possession; 12% for sales and manufacturing. The overall arrest figure dropped just 1%. There were 749,825 pot arrests in 2012, 757,969 in 2011 and 853,638 in 2010. Of the 1.5 million drug arrests in 2013, nearly half (46%) were for cannabis. Drug arrests accounted for 13% of all arrests (11.3 million). Other leading offenses are property crime (1.5 million), larceny (1.2 million) and DUI (1.1 million).

New York City Police Commissioner Bill Bratton whimsically held up a baggie filled with oregano to show what 25 grams (about an ounce) of herb looks like in announcing the new policy to stop making arrests for those found in possession of that much cannabis in public view. The policy is expected to curb the tens of thousands of arrests for low-level possession the NYPD makes each year—busts that disproportionately affect Black and Latino residents despite the fact that whites use the herb no less. Despite New York State's 1976 decriminalization law, the Big Apple has remained the marijuana arrest capital of the world—and arrests have actually increased since the supposedly progressive Mayor Bill de Blasio took office this year. Pot in public view is what is critical—allowing police to make arrests for what would otherwise be just a ticketable offense. But even under the new policy, possession in public view can still get you a summons and a $100 fine, and those smoking in public will still be subject to arrest.

In the Nov. 4 elections, voters in Washington DC approved Initiative 71, a legalization measure allowing residents to grow up to six plants at home and possess up to two ounces. The victory portends a showdown with Congress, as the Republicans will now control both houses. Oregon approved Measure 91, a legalization measure giving regulatory control to the state liquor control agency and allowing Oregon citizens to grow up to four plants. We continue to await word on a legalization measure in Alaska. A medical marijuana measure in Florida was defeated. Guam became the first US territory to pass a medical marijuana measure. (Reuters, NPR, Smell The Truth)

On New Year’s Day, as retail sales of cannabis went legal in Colorado, the state's dispensaries registered well over $1 million in sales. Despite cold and wet weather, most of the 36 shops that opened that day reported long lines, with some customers waiting outdoors for hours. By the end of the first week, by which time another dozen retail outlets had opened, the figure was a whopping $5 million. More than 100 dispensaries in the Centennial State have now received licenses for retail cannabis sales and over 500 are eligible to apply. More are applying every day.

"A new industry is developing in a nascent state in Colorado," says Rachel Gillette, director of the Colorado chapter of the National Organization for the Reform of Marijuana Laws (NORML). "We're not just talking about retail sales, but a lot of other types of business associated with it—construction companies, HVAC contractors, nutrient companies, lighting and equipment sales, packaging, printers, labeling, marketing materials, websites, marijuana tourism, attorneys, payroll companies… This could represent a lot of jobs."

The US District Court for the Eastern District of California will hold rare formal hearings beginning Oct. 27 to determine whether an indictment against Brian Justin Pickard and others for conspiracy to grow more than 1,000 marijuana plants violates the US Constitution, and whether marijuana is misclassified by the federal government as a dangerous drug with no medical value. US District Judge Kimberly J. Mueller will preside over the three-day hearing, which includes expert testimony from doctors Carl Hart, associate professor of psychology at Columbia University in New York; Greg Carter, medical director of St. Luke's Rehabilitation Institute in Spokane, Wash., and expert witness Chris Conrad.